Madhukar H. Trivedi, M.D.

JCP
Commentary

May 19, 2020

Read commentary on inadequate antidepressant response for MDD. Determining where patients are on the response continuum and managing inadequate response.
, , , et al
JCP
Overcoming Challenges to Treat Inadequate Response in MDD
Educational Activity

May 12, 2020

How do you determine if a patient is experiencing nonresponse to an antidepressant? In this activity, experts discuss augmentation and adjunctive treatment strategies, as well as best practices for...
, , , et al
JCP
Augmentation and Adjunctive Strategies for Inadequate Response in MDD
Educational Activity

May 12, 2020

When a patient with major depressive disorder isn't responding to antidepressant treatment, what are your next moves? In this activity, learn from the experts about augmentation and adjunctive strategies.
, , , et al
JCP
Recognizing Inadequate Response in Patients With MDD
Educational Activity

May 5, 2020

Can you recognize inadequate antidepressant response? How does it differ from treatment-resistant depression? In this activity, experts discuss definitions of response as well as residual symptoms seen with inadequate...
, , , et al
JCP
Use of Measurement-Based Care to Address Inadequate Antidepressant Response
Educational Activity

May 5, 2020

You may think using rating scales to measure depression symptoms takes too long. But that time may be well spent. In this activity, experts discuss the value of measurement-based...
, , , et al
JCP
Educational Activity

March 17, 2020

When you are treating a patient for depression, do you regularly assess symptoms, adherence, and side effects using tools and then use that information to guide treatment decisions? Learn...
JCP
Educational Activity

March 17, 2020

Identification of depression is crucial, as untreated depression is linked to functional impairment and suicide. Learn from an expert about how measurement-based care provides a way to improve the...
JCP
Original Research

September 24, 2019

The use of atypical antipsychotics as adjunctive treatment for nonresponsive depression is limited by their side effects. This study explores whether pimavanserin can be both an efficacious and tolerable...
, , , et al
JCP
Original Research

January 9, 2018

The self-report Concise Associated Symptoms Tracking Scale (CAST-SR) was designed to track symptoms such as mania and anxiety in depressed outpatients being treated with antidepressants. This study used data...
, , , et al
JCP
Academic Highlights

November 28, 2017

Many of your patients with depression also experience anxiety symptoms, and addressing these symptoms is a crucial part of successful treatment. Explore this free Academic Highlights activity to learn...
, , , et al
PCC
Article

October 19, 2017

Research on behavioral activation teletherapy is limited. Learn about a brief behavioral activation teletherapy program for depression and anxiety in a study describing results among low-income, real-world primary care...
, , , et al
JCP
Original Research

April 26, 2017

Do depressed patients with comorbid panic disorder have antidepressant treatment side effect profiles that differ from those of patients without panic disorder? Check out this article to review the...
, , , et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe